Hepidermal Growth Factor Receptor 2 (updated 2024-12-02)

AntibodyDrug Conjugates and Endometrial Cancer Combinations Response Rates and Clinical Trials

Duration: 27:34
112 views | 5 months ago

The Growth Factor Receptor and PI3K AKT mTOR Pathway Part 4

Duration: 17:23
7.3K views | 7 Nov 2014

Utility of Fine Needle Aspiration Cytology in Assessing Breast Cancer Biomarkers

Duration: 3:13
2K views | 13 Jan 2015

The Vascular Endothelial Growth Factor Part 5

Duration: 35:03
103 views | 8 months ago

FDA DISCO Burst Edition FDA approvals of Verzenio abemaciclib for adjuvant treatment of a

Duration: 7:01
87 views | 3 months ago

Common Sense Oncology Journal Club Breast Cancer

Duration: 59:18
2 views | 7 months ago

Extending the Reach of Targeted Therapy for Hormone ReceptorPositive Advanced Breast Cancer

Duration: 9:55
69 views | 1 month ago

Deciphering the Latest Clinical Data for EGFRMutated Advanced NSCLC Unveiling Expert Insights

Duration: 32:31
13.3K views | 27 Apr 2011

Difference Between Growth Rate and Growth Factor

Duration: 3:45
531 views | 4 months ago

What Do We Need to Know About New Therapeutics for Patients With Endometrial Cancer

Duration: 26:00
8 views | 5 months ago

Glimpse of Aberrant Glycosylation in cancer cells Part2 Code 569

Duration: 6:07
4 views | 5 months ago

Understanding the Concerns and Challenges of Patients With HRPositiveHER2Negative EBC Expert

Duration: 25:52
12.5K views | 4 Oct 2011

The Molecular Tumor Board Best Practices for Managing Primary and Acquired EGFR TKI Resistance

Duration: 45:12
78 views | 8 months ago

CERE110 Nerve Growth Factor Study Medical Animation

Duration: 2:38
104 views | 3 weeks ago

FDA DISCO Burst Edition FDA approvals of Lumakras sotorasib for patients with KRAS G12C

Duration: 6:31
47 views | 1 month ago

Lung Cancer Screening Critical Conversations with LUNGevity

Duration: 27:21
149 views | 17 Nov 2023

Hormone Receptor Status in Breast Cancer ER PR or HER2 status Dr Vivek Belathur Precision

Duration: 5:31
85 views | 5 months ago

Prognostic score in early HRHER2 breast cancer RS factors mutations histology

Duration: 3:06
448 views | 5 months ago

Trastuzumab deruxtecan significantly improves PFS In breast cancer patients previously treated w

Duration: 4:03
24 views | 2 months ago

What EGFRHER2 Vaccine Targets

Duration: 0:47
5.5K views | 9 Jul 2018

New daily tablet treatment recommended for rare form of advanced bile duct cancer

Duration: 0:44
30 views | 1 month ago

Tumor necrosis factor receptor signaling Biochemistry

Duration: 4:35
82 views | 9 months ago

Poster Spotlight Prognostic and Predictive Uses of Cell Free DNA

Duration: 1:00:45
4 views | 5 months ago

Innovative Nanogel Composites for Targeted Breast Cancer Therapy and Bioimaging

Duration: 2:53
78 views | 5 months ago

Sacituzumab Govitecan with Platinum Chemotherapy Antitumor Effects Oncotarget

Duration: 2:17
61K views | 6 Dec 2012

FISH HER2 ERBB2 AMPLIFICATION

Duration: 2:03
884 views | 10 months ago

Pertuzumab Perjeta Injection Uses Dosage Mechanism Side Effects and Important Advice

Duration: 4:05
2.9K views | 13 Jan 2015

How I found out I had breast cancer

Duration: 10:55
|

Approval of Capivasertib for PIK3CAAKT1PTEN–Altered Breast Cancer Jason Mouabbi and Carlos Doti

Duration: 14:02
|

The Vascular Endothelial Growth Factor Part 4

Duration: 23:47
|